BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31758326)

  • 1. Utility of topical agents for radiation dermatitis and pain: a randomized clinical trial.
    Ryan Wolf J; Gewandter JS; Bautista J; Heckler CE; Strasser J; Dyk P; Anderson T; Gross H; Speer T; Dolohanty L; Bylund K; Pentland AP; Morrow GR
    Support Care Cancer; 2020 Jul; 28(7):3303-3311. PubMed ID: 31758326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral curcumin for radiation dermatitis: a URCC NCORP study of 686 breast cancer patients.
    Ryan Wolf J; Heckler CE; Guido JJ; Peoples AR; Gewandter JS; Ling M; Vinciguerra VP; Anderson T; Evans L; Wade J; Pentland AP; Morrow GR
    Support Care Cancer; 2018 May; 26(5):1543-1552. PubMed ID: 29192329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients.
    Ryan JL; Heckler CE; Ling M; Katz A; Williams JP; Pentland AP; Morrow GR
    Radiat Res; 2013 Jul; 180(1):34-43. PubMed ID: 23745991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Nano-Curcumin on Radiotherapy-Induced Skin Reaction in Breast Cancer Patients: A Randomized, Triple-Blind, Placebo-Controlled Trial.
    Talakesh T; Tabatabaee N; Atoof F; Aliasgharzadeh A; Sarvizade M; Farhood B; Najafi M
    Curr Radiopharm; 2022; 15(4):332-340. PubMed ID: 35747962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical corticosteroid therapy for acute radiation dermatitis: a prospective, randomized, double-blind study.
    Schmuth M; Wimmer MA; Hofer S; Sztankay A; Weinlich G; Linder DM; Elias PM; Fritsch PO; Fritsch E
    Br J Dermatol; 2002 Jun; 146(6):983-91. PubMed ID: 12072066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter Randomized Double-Blind, Placebo-Controlled Trial GORTEC (Groupe Oncologie Radiotherapie Tete et Cou) 2009-01 Evaluating the Effect of the Regenerating Agent on Radiodermatitis of Head and Neck Cancer Patients.
    Tao Y; Auperin A; Sire C; Martin M; Saliou MG; Bardet E; Sun XS; Chatellier T; Morand C; Cornely A; Angokai M; Di Rito A; Kichenin K; Blanchard P; D'Onofrio I; Bourhis J
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):590-595. PubMed ID: 29280453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, Prospective, Open-label Phase III Trial Comparing Mebo Ointment With Biafine Cream for the Management of Acute Dermatitis During Radiotherapy for Breast Cancer.
    Geara FB; Eid T; Zouain N; Thebian R; Andraos T; Chehab C; Ramia P; Youssef B; Zeidan YH
    Am J Clin Oncol; 2018 Dec; 41(12):1257-1262. PubMed ID: 29889137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical use of recombinant human epidermal growth factor (EGF)-based cream to prevent radiation dermatitis in breast cancer patients: a single-blind randomized preliminary study.
    Kong M; Hong SE
    Asian Pac J Cancer Prev; 2013; 14(8):4859-64. PubMed ID: 24083759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal Topical Agent for Radiation Dermatitis During Breast Radiotherapy: A Pilot Study.
    Fenton-Kerimian M; Cartwright F; Peat E; Florentino R; Maisonet O; Budin W; Rolnitzky L; Formenti S
    Clin J Oncol Nurs; 2015 Aug; 19(4):451-5. PubMed ID: 26207710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical atorvastatin 1% for prevention of skin toxicity in patients receiving radiation therapy for breast cancer: a randomized, double-blind, placebo-controlled trial.
    Ghasemi A; Ghashghai Z; Akbari J; Yazdani-Charati J; Salehifar E; Hosseinimehr SJ
    Eur J Clin Pharmacol; 2019 Feb; 75(2):171-178. PubMed ID: 30291370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized Double-blind Placebo-controlled Trial of Celecoxib for the Prevention of Skin Toxicity in Patients Receiving Radiation Therapy for Breast Cancer.
    Ghasemi A; Danesh B; Yazdani-Charati J; Hosseinimehr SJ
    Antiinflamm Antiallergy Agents Med Chem; 2018; 17(1):57-67. PubMed ID: 29651970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic treatment with a potent corticosteroid cream ameliorates radiodermatitis, independent of radiation schedule: A randomized double blinded study.
    Ulff E; Maroti M; Serup J; Nilsson M; Falkmer U
    Radiother Oncol; 2017 Jan; 122(1):50-53. PubMed ID: 27913066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I study of topical epigallocatechin-3-gallate (EGCG) in patients with breast cancer receiving adjuvant radiotherapy.
    Zhao H; Zhu W; Jia L; Sun X; Chen G; Zhao X; Li X; Meng X; Kong L; Xing L; Yu J
    Br J Radiol; 2016; 89(1058):20150665. PubMed ID: 26607642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical steroid versus placebo for the prevention of radiation dermatitis in head and neck cancer patients receiving chemoradiotherapy: the study protocol of J-SUPPORT 1602 (TOPICS study), a randomized double-blinded phase 3 trial.
    Zenda S; Yamaguchi T; Yokota T; Miyaji T; Mashiko T; Tanaka M; Yonemura M; Takeno M; Okano T; Kawasaki T; Nakamori Y; Ishii S; Shimada S; Kanamaru M; Uchitomi Y
    BMC Cancer; 2018 Sep; 18(1):873. PubMed ID: 30189840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nigella sativa L. for prevention of acute radiation dermatitis in breast cancer: A randomized, double-blind, placebo-controlled, clinical trial.
    Rafati M; Ghasemi A; Saeedi M; Habibi E; Salehifar E; Mosazadeh M; Maham M
    Complement Ther Med; 2019 Dec; 47():102205. PubMed ID: 31780017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of topical timolol for the prevention of radiation-induced dermatitis in breast cancer: a pilot triple-blind, placebo-controlled trial.
    Nabi-Meybodi M; Sahebnasagh A; Hakimi Z; Shabani M; Shakeri AA; Saghafi F
    BMC Cancer; 2022 Oct; 22(1):1079. PubMed ID: 36266613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis: results from a double-blind, randomized study.
    Boström A; Lindman H; Swartling C; Berne B; Bergh J
    Radiother Oncol; 2001 Jun; 59(3):257-65. PubMed ID: 11369066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactically applied Hydrofilm polyurethane film dressings reduce radiation dermatitis in adjuvant radiation therapy of breast cancer patients.
    Schmeel LC; Koch D; Stumpf S; Leitzen C; Simon B; Schüller H; Vornholt S; Schoroth F; Müdder T; Röhner F; Garbe S; Schmeel FC; Schild HH; Wilhelm-Buchstab TM
    Acta Oncol; 2018 Jul; 57(7):908-915. PubMed ID: 29463159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A potent steroid cream is superior to emollients in reducing acute radiation dermatitis in breast cancer patients treated with adjuvant radiotherapy. A randomised study of betamethasone versus two moisturizing creams.
    Ulff E; Maroti M; Serup J; Falkmer U
    Radiother Oncol; 2013 Aug; 108(2):287-92. PubMed ID: 23827771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Curcumin Supplementation on Radiation Dermatitis Severity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Mirzaei Dahka S; Afsharfar M; Tajaddod S; Sohouli MH; Shekari S; Bakhshi Nafouti F; Alizadeh A; Shafahi Kachaei H; Abbasi K; Khalatbari Mohseni G; Alami F; Gholamalizadeh M; Doaei S
    Asian Pac J Cancer Prev; 2023 Mar; 24(3):783-789. PubMed ID: 36974529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.